Last update 21 Nov 2024
SLC-3010
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism IL-2 inhibitors(Interleukin-2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization  Selecxine, Inc. Co Ltd.Startup |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with SLC-3010A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination With Various Anticancer Therapies in Patients With Advanced Solid Tumors
100 Clinical Results associated with SLC-3010
Login to view more data
100 Translational Medicine associated with SLC-3010
Login to view more data
100 Patents (Medical) associated with SLC-3010
Login to view more data
100 Deals associated with SLC-3010
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 2 | US | Selecxine, Inc. Co Ltd.Startup | 21 Dec 2022 |
| Advanced Malignant Solid Neoplasm | Phase 2 | AU | Selecxine, Inc. Co Ltd.Startup | 21 Dec 2022 |
| Advanced Malignant Solid Neoplasm | Phase 2 | KR | Selecxine, Inc. Co Ltd.Startup | 21 Dec 2022 |
| Neoplasms | Preclinical | US | - |
Login to view more data
Clinical Result
Clinical Result
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free